NECG Notes: Sudafed gets Meth Sick
NECG Notes -From The New England Consulting Group
Release Date: 04/27/2019
Go East YUM Brand!
NECG Notes -From The New England Consulting Group
David Stone, a Managing Partner at the New England Consulting Group recalls the three decisions he and his management team made when they (PepsiCo) bought Taco Bell and began to expand the brand's footprint nationally. The lessons learned then still apply to many of the challenges and opportunities facing the fast-casual category today.
info_outline
Episode 6- NECG puts the crunch back in Cheetos
NECG Notes -From The New England Consulting Group
It may be hard to believe but in the early 1980s, Frito Lay's Cheetos Brand was at risk of becoming an unsupported harvest brand. Enter the New England Consulting Group who with the help of a smart client and a wonderfully creative advertising character put the brand on a course to grow 10X over the decade that followed. Take a few minutes to listen to the story of Cheetos turnaround and the birth of Chestah Cheetah!
info_outline
NECG Notes: New England Delivers For Cardinal Health
NECG Notes -From The New England Consulting Group
Join Steven Robins and David Stone as they talk about the work that NECG did for Cardinal Health one of the world's largest medical distributors and medical services companies. The New England Consulting Group helped Cardinal organize and optimize the way they presented these businesses to the marketplace and thought about them inside the Cardinal machine.
info_outline
NECG Notes: Sudafed gets Meth Sick
NECG Notes -From The New England Consulting Group
What do you do when a product that has a legitimate use is overwhelmed by an illegal one? Methamphetamine use in the US started to grow rapidly in the 1990s driven primarily by Mexican poly-drug cartels. Unfortunately, Pseudoephedrine, the active nasal decongestant ingredient in Sudafed and many other cold and allergy products was one of the precursor chemicals that meth makers used. NECG Managing Partner David Stone talks with Steven Robins who was the Category Director at Pfizer Consumer Healthcare when the "Meth hit the fan."
info_outline
NECG Helps Wake Up Beautyrest
NECG Notes -From The New England Consulting Group
Before Casper and Purple, and others figured out that you could sell mattresses to consumers without middlemen, there was Tempurpedic who disrupted the category by offering a technological innovation, memory foam, into a new channel, direct-to- consumer. NECG worked with the market leader Simmons to respond to this threat by evolving their innovation model and branding constructs. As you will see, the result was a new, premium sub-brand that woke up the brand.
info_outline
NECG Helps Stanley Tools Nail It
NECG Notes -From The New England Consulting Group
In this Episode of New England Notes we learn what Stanley Tools did to grow rapidly in a very unfriendly environment. With an emphasis on segmentation and language, Contractor Grade was born!
info_outline
NECG Notes Episode 1- Atkins on the Ropes
NECG Notes -From The New England Consulting Group
Before the Keto and Paleo diets, there was Atkins. A pioneer in low carbohydrate nutrition, Atkins is and was a powerhouse brand in the weight loss industry but it wasn't always successful. After growing to nearly $750 Million in the late 1990s the Atkins diet was over extended and in serious peril. The brand was in decline, and the company was facing liquidation. The bankers in charge of Atkins' fate reached out to the New England Consulting Group to get an evaluation of whether or not they should pull the plug. Join NECG's Founder, Gary Stibel as he talks with Managing...
info_outlineWhat do you do when a product that has a legitimate use is overwhelmed by an illegal one? Methamphetamine use in the US started to grow rapidly in the 1990s driven primarily by Mexican poly-drug cartels. Unfortunately, Pseudoephedrine, the active nasal decongestant ingredient in Sudafed and many other cold and allergy products was one of the precursor chemicals that meth makers used. NECG Managing Partner David Stone talks with Steven Robins who was the Category Director at Pfizer Consumer Healthcare when the "Meth hit the fan."